Prevalence of Lung Cancer Screening in the US, 2022
This cross-sectional study compares lung cancer screening prevalence in 2022 among individuals eligible by 2021 vs 2013 criteria by sociodemographics and state.
Authors
- Louise M. Henderson (ORCID: https://orcid.org/0000-0001-8356-9267)
- I‐Hsuan Su (ORCID: https://orcid.org/0000-0002-2916-4397)
- Daniel S. Reuland (ORCID: https://orcid.org/0000-0002-7839-6581)
- Jennifer L. Lund (ORCID: https://orcid.org/0000-0002-1108-0689)
- Xiaomeng Chen (ORCID: https://orcid.org/0000-0001-9620-7361)
- M. Patricia Rivera (ORCID: https://orcid.org/0000-0003-3827-5010)
- Joyce Pak (ORCID: https://orcid.org/0000-0003-2443-7971)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2024-11-06
- DOI
- https://doi.org/10.17615/v13h-xv23
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- National Institutes of Health
- National Cancer Institute